nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—rheumatoid arthritis	0.172	1	CbGaD
Fluoxetine—ALB—Auranofin—rheumatoid arthritis	0.0804	0.146	CbGbCtD
Fluoxetine—CYP1A2—Leflunomide—rheumatoid arthritis	0.031	0.0564	CbGbCtD
Fluoxetine—CYP2C9—Leflunomide—rheumatoid arthritis	0.0279	0.0509	CbGbCtD
Fluoxetine—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0257	0.0468	CbGbCtD
Fluoxetine—ALB—Prednisone—rheumatoid arthritis	0.0256	0.0466	CbGbCtD
Fluoxetine—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0221	0.0402	CbGbCtD
Fluoxetine—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0207	0.0376	CbGbCtD
Fluoxetine—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0195	0.0355	CbGbCtD
Fluoxetine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.018	0.0327	CbGbCtD
Fluoxetine—CYP2C19—Prednisone—rheumatoid arthritis	0.0166	0.0302	CbGbCtD
Fluoxetine—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0163	0.0297	CbGbCtD
Fluoxetine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0157	0.0286	CbGbCtD
Fluoxetine—ABCB1—Betamethasone—rheumatoid arthritis	0.0144	0.0262	CbGbCtD
Fluoxetine—ABCB1—Prednisolone—rheumatoid arthritis	0.0142	0.0258	CbGbCtD
Fluoxetine—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0134	0.0245	CbGbCtD
Fluoxetine—ABCB1—Prednisone—rheumatoid arthritis	0.0134	0.0244	CbGbCtD
Fluoxetine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0132	0.0241	CbGbCtD
Fluoxetine—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0131	0.0238	CbGbCtD
Fluoxetine—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0128	0.0234	CbGbCtD
Fluoxetine—ALB—Methotrexate—rheumatoid arthritis	0.0128	0.0234	CbGbCtD
Fluoxetine—ABCB1—Cyclosporine—rheumatoid arthritis	0.0127	0.0231	CbGbCtD
Fluoxetine—CYP2D6—Cyclosporine—rheumatoid arthritis	0.012	0.0218	CbGbCtD
Fluoxetine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.0104	0.0189	CbGbCtD
Fluoxetine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.01	0.0183	CbGbCtD
Fluoxetine—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00861	0.0157	CbGbCtD
Fluoxetine—CYP3A4—Betamethasone—rheumatoid arthritis	0.00861	0.0157	CbGbCtD
Fluoxetine—CYP3A4—Prednisolone—rheumatoid arthritis	0.0085	0.0155	CbGbCtD
Fluoxetine—ABCB1—Dexamethasone—rheumatoid arthritis	0.00836	0.0152	CbGbCtD
Fluoxetine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00805	0.0147	CbGbCtD
Fluoxetine—CYP3A4—Prednisone—rheumatoid arthritis	0.00802	0.0146	CbGbCtD
Fluoxetine—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00788	0.0143	CbGbCtD
Fluoxetine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00761	0.0138	CbGbCtD
Fluoxetine—ABCB1—Methotrexate—rheumatoid arthritis	0.00672	0.0122	CbGbCtD
Fluoxetine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00501	0.00912	CbGbCtD
Fluoxetine—SIGMAR1—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000968	1	CbGdCrCtD
Fluoxetine—Urticaria—Cyclosporine—rheumatoid arthritis	6.41e-05	0.000239	CcSEcCtD
Fluoxetine—Myalgia—Betamethasone—rheumatoid arthritis	6.39e-05	0.000238	CcSEcCtD
Fluoxetine—Myalgia—Dexamethasone—rheumatoid arthritis	6.39e-05	0.000238	CcSEcCtD
Fluoxetine—Abdominal pain—Cyclosporine—rheumatoid arthritis	6.37e-05	0.000238	CcSEcCtD
Fluoxetine—Body temperature increased—Cyclosporine—rheumatoid arthritis	6.37e-05	0.000238	CcSEcCtD
Fluoxetine—Anxiety—Dexamethasone—rheumatoid arthritis	6.36e-05	0.000238	CcSEcCtD
Fluoxetine—Anxiety—Betamethasone—rheumatoid arthritis	6.36e-05	0.000238	CcSEcCtD
Fluoxetine—Discomfort—Dexamethasone—rheumatoid arthritis	6.31e-05	0.000236	CcSEcCtD
Fluoxetine—Discomfort—Betamethasone—rheumatoid arthritis	6.31e-05	0.000236	CcSEcCtD
Fluoxetine—Dyspepsia—Hydrocortisone—rheumatoid arthritis	6.31e-05	0.000236	CcSEcCtD
Fluoxetine—Haemoglobin—Methotrexate—rheumatoid arthritis	6.3e-05	0.000235	CcSEcCtD
Fluoxetine—Hypotension—Methylprednisolone—rheumatoid arthritis	6.29e-05	0.000235	CcSEcCtD
Fluoxetine—Pain—Prednisolone—rheumatoid arthritis	6.27e-05	0.000234	CcSEcCtD
Fluoxetine—Haemorrhage—Methotrexate—rheumatoid arthritis	6.27e-05	0.000234	CcSEcCtD
Fluoxetine—Hepatitis—Methotrexate—rheumatoid arthritis	6.27e-05	0.000234	CcSEcCtD
Fluoxetine—Decreased appetite—Hydrocortisone—rheumatoid arthritis	6.23e-05	0.000233	CcSEcCtD
Fluoxetine—Pharyngitis—Methotrexate—rheumatoid arthritis	6.23e-05	0.000232	CcSEcCtD
Fluoxetine—Nausea—Leflunomide—rheumatoid arthritis	6.21e-05	0.000232	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	6.19e-05	0.000231	CcSEcCtD
Fluoxetine—Fatigue—Hydrocortisone—rheumatoid arthritis	6.18e-05	0.000231	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	6.15e-05	0.00023	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	6.13e-05	0.000229	CcSEcCtD
Fluoxetine—Pain—Hydrocortisone—rheumatoid arthritis	6.13e-05	0.000229	CcSEcCtD
Fluoxetine—Anaphylactic shock—Betamethasone—rheumatoid arthritis	6.12e-05	0.000229	CcSEcCtD
Fluoxetine—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	6.12e-05	0.000229	CcSEcCtD
Fluoxetine—Insomnia—Triamcinolone—rheumatoid arthritis	6.1e-05	0.000228	CcSEcCtD
Fluoxetine—Insomnia—Methylprednisolone—rheumatoid arthritis	6.09e-05	0.000227	CcSEcCtD
Fluoxetine—Infection—Dexamethasone—rheumatoid arthritis	6.08e-05	0.000227	CcSEcCtD
Fluoxetine—Infection—Betamethasone—rheumatoid arthritis	6.08e-05	0.000227	CcSEcCtD
Fluoxetine—Ill-defined disorder—Prednisone—rheumatoid arthritis	6.06e-05	0.000226	CcSEcCtD
Fluoxetine—Paraesthesia—Triamcinolone—rheumatoid arthritis	6.06e-05	0.000226	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisolone—rheumatoid arthritis	6.05e-05	0.000226	CcSEcCtD
Fluoxetine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	6.05e-05	0.000226	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—rheumatoid arthritis	6.04e-05	0.000226	CcSEcCtD
Fluoxetine—Anaemia—Prednisone—rheumatoid arthritis	6.04e-05	0.000225	CcSEcCtD
Fluoxetine—Shock—Dexamethasone—rheumatoid arthritis	6.02e-05	0.000225	CcSEcCtD
Fluoxetine—Shock—Betamethasone—rheumatoid arthritis	6.02e-05	0.000225	CcSEcCtD
Fluoxetine—Dyspnoea—Triamcinolone—rheumatoid arthritis	6.02e-05	0.000225	CcSEcCtD
Fluoxetine—Agitation—Prednisone—rheumatoid arthritis	6e-05	0.000224	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.99e-05	0.000224	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.99e-05	0.000224	CcSEcCtD
Fluoxetine—Tachycardia—Betamethasone—rheumatoid arthritis	5.98e-05	0.000223	CcSEcCtD
Fluoxetine—Tachycardia—Dexamethasone—rheumatoid arthritis	5.98e-05	0.000223	CcSEcCtD
Fluoxetine—Angioedema—Prednisone—rheumatoid arthritis	5.97e-05	0.000223	CcSEcCtD
Fluoxetine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	5.94e-05	0.000222	CcSEcCtD
Fluoxetine—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.94e-05	0.000222	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—rheumatoid arthritis	5.93e-05	0.000221	CcSEcCtD
Fluoxetine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.93e-05	0.000221	CcSEcCtD
Fluoxetine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	5.92e-05	0.000221	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	5.92e-05	0.000221	CcSEcCtD
Fluoxetine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	5.91e-05	0.00022	CcSEcCtD
Fluoxetine—Malaise—Prednisone—rheumatoid arthritis	5.89e-05	0.00022	CcSEcCtD
Fluoxetine—Vertigo—Prednisone—rheumatoid arthritis	5.87e-05	0.000219	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.86e-05	0.000219	CcSEcCtD
Fluoxetine—Syncope—Prednisone—rheumatoid arthritis	5.86e-05	0.000219	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—rheumatoid arthritis	5.85e-05	0.000218	CcSEcCtD
Fluoxetine—Anorexia—Dexamethasone—rheumatoid arthritis	5.84e-05	0.000218	CcSEcCtD
Fluoxetine—Anorexia—Betamethasone—rheumatoid arthritis	5.84e-05	0.000218	CcSEcCtD
Fluoxetine—Urticaria—Prednisolone—rheumatoid arthritis	5.83e-05	0.000218	CcSEcCtD
Fluoxetine—Fatigue—Triamcinolone—rheumatoid arthritis	5.82e-05	0.000217	CcSEcCtD
Fluoxetine—Fatigue—Methylprednisolone—rheumatoid arthritis	5.8e-05	0.000217	CcSEcCtD
Fluoxetine—Asthenia—Cyclosporine—rheumatoid arthritis	5.79e-05	0.000216	CcSEcCtD
Fluoxetine—Pain—Triamcinolone—rheumatoid arthritis	5.77e-05	0.000215	CcSEcCtD
Fluoxetine—Loss of consciousness—Prednisone—rheumatoid arthritis	5.74e-05	0.000214	CcSEcCtD
Fluoxetine—Hypotension—Betamethasone—rheumatoid arthritis	5.72e-05	0.000214	CcSEcCtD
Fluoxetine—Hypotension—Dexamethasone—rheumatoid arthritis	5.72e-05	0.000214	CcSEcCtD
Fluoxetine—Pruritus—Cyclosporine—rheumatoid arthritis	5.7e-05	0.000213	CcSEcCtD
Fluoxetine—Urticaria—Hydrocortisone—rheumatoid arthritis	5.69e-05	0.000213	CcSEcCtD
Fluoxetine—Abdominal pain—Hydrocortisone—rheumatoid arthritis	5.67e-05	0.000211	CcSEcCtD
Fluoxetine—Body temperature increased—Hydrocortisone—rheumatoid arthritis	5.67e-05	0.000211	CcSEcCtD
Fluoxetine—Convulsion—Prednisone—rheumatoid arthritis	5.66e-05	0.000211	CcSEcCtD
Fluoxetine—Hypertension—Prednisone—rheumatoid arthritis	5.64e-05	0.000211	CcSEcCtD
Fluoxetine—Chills—Methotrexate—rheumatoid arthritis	5.63e-05	0.00021	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	5.58e-05	0.000208	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	5.58e-05	0.000208	CcSEcCtD
Fluoxetine—Myalgia—Prednisone—rheumatoid arthritis	5.56e-05	0.000208	CcSEcCtD
Fluoxetine—Arthralgia—Prednisone—rheumatoid arthritis	5.56e-05	0.000208	CcSEcCtD
Fluoxetine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	5.56e-05	0.000208	CcSEcCtD
Fluoxetine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	5.55e-05	0.000207	CcSEcCtD
Fluoxetine—Anxiety—Prednisone—rheumatoid arthritis	5.54e-05	0.000207	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—rheumatoid arthritis	5.54e-05	0.000207	CcSEcCtD
Fluoxetine—Insomnia—Dexamethasone—rheumatoid arthritis	5.54e-05	0.000207	CcSEcCtD
Fluoxetine—Insomnia—Betamethasone—rheumatoid arthritis	5.54e-05	0.000207	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	5.52e-05	0.000206	CcSEcCtD
Fluoxetine—Diarrhoea—Cyclosporine—rheumatoid arthritis	5.52e-05	0.000206	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	5.51e-05	0.000206	CcSEcCtD
Fluoxetine—Paraesthesia—Betamethasone—rheumatoid arthritis	5.5e-05	0.000205	CcSEcCtD
Fluoxetine—Paraesthesia—Dexamethasone—rheumatoid arthritis	5.5e-05	0.000205	CcSEcCtD
Fluoxetine—Discomfort—Prednisone—rheumatoid arthritis	5.5e-05	0.000205	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—rheumatoid arthritis	5.5e-05	0.000205	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—rheumatoid arthritis	5.46e-05	0.000204	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisolone—rheumatoid arthritis	5.41e-05	0.000202	CcSEcCtD
Fluoxetine—Dyspepsia—Betamethasone—rheumatoid arthritis	5.39e-05	0.000201	CcSEcCtD
Fluoxetine—Dyspepsia—Dexamethasone—rheumatoid arthritis	5.39e-05	0.000201	CcSEcCtD
Fluoxetine—Urticaria—Triamcinolone—rheumatoid arthritis	5.36e-05	0.0002	CcSEcCtD
Fluoxetine—Urticaria—Methylprednisolone—rheumatoid arthritis	5.35e-05	0.0002	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—rheumatoid arthritis	5.35e-05	0.0002	CcSEcCtD
Fluoxetine—Body temperature increased—Triamcinolone—rheumatoid arthritis	5.33e-05	0.000199	CcSEcCtD
Fluoxetine—Dizziness—Cyclosporine—rheumatoid arthritis	5.33e-05	0.000199	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisone—rheumatoid arthritis	5.33e-05	0.000199	CcSEcCtD
Fluoxetine—Abdominal pain—Methylprednisolone—rheumatoid arthritis	5.32e-05	0.000199	CcSEcCtD
Fluoxetine—Decreased appetite—Dexamethasone—rheumatoid arthritis	5.32e-05	0.000199	CcSEcCtD
Fluoxetine—Decreased appetite—Betamethasone—rheumatoid arthritis	5.32e-05	0.000199	CcSEcCtD
Fluoxetine—Infection—Prednisone—rheumatoid arthritis	5.3e-05	0.000198	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	5.29e-05	0.000197	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	5.29e-05	0.000197	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—rheumatoid arthritis	5.28e-05	0.000197	CcSEcCtD
Fluoxetine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	5.28e-05	0.000197	CcSEcCtD
Fluoxetine—Fatigue—Dexamethasone—rheumatoid arthritis	5.28e-05	0.000197	CcSEcCtD
Fluoxetine—Fatigue—Betamethasone—rheumatoid arthritis	5.28e-05	0.000197	CcSEcCtD
Fluoxetine—Shock—Prednisone—rheumatoid arthritis	5.25e-05	0.000196	CcSEcCtD
Fluoxetine—Pain—Betamethasone—rheumatoid arthritis	5.24e-05	0.000195	CcSEcCtD
Fluoxetine—Pain—Dexamethasone—rheumatoid arthritis	5.24e-05	0.000195	CcSEcCtD
Fluoxetine—Tachycardia—Prednisone—rheumatoid arthritis	5.2e-05	0.000194	CcSEcCtD
Fluoxetine—Skin disorder—Prednisone—rheumatoid arthritis	5.18e-05	0.000193	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisone—rheumatoid arthritis	5.15e-05	0.000192	CcSEcCtD
Fluoxetine—Asthenia—Hydrocortisone—rheumatoid arthritis	5.14e-05	0.000192	CcSEcCtD
Fluoxetine—Vomiting—Cyclosporine—rheumatoid arthritis	5.13e-05	0.000191	CcSEcCtD
Fluoxetine—Rash—Cyclosporine—rheumatoid arthritis	5.08e-05	0.00019	CcSEcCtD
Fluoxetine—Anorexia—Prednisone—rheumatoid arthritis	5.08e-05	0.00019	CcSEcCtD
Fluoxetine—Dermatitis—Cyclosporine—rheumatoid arthritis	5.08e-05	0.00019	CcSEcCtD
Fluoxetine—Pruritus—Hydrocortisone—rheumatoid arthritis	5.07e-05	0.000189	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—rheumatoid arthritis	5.07e-05	0.000189	CcSEcCtD
Fluoxetine—Headache—Cyclosporine—rheumatoid arthritis	5.05e-05	0.000189	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—rheumatoid arthritis	5.05e-05	0.000188	CcSEcCtD
Fluoxetine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	5.05e-05	0.000188	CcSEcCtD
Fluoxetine—Feeling abnormal—Betamethasone—rheumatoid arthritis	5.05e-05	0.000188	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	5.01e-05	0.000187	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	5.01e-05	0.000187	CcSEcCtD
Fluoxetine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.97e-05	0.000186	CcSEcCtD
Fluoxetine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.96e-05	0.000185	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—rheumatoid arthritis	4.92e-05	0.000184	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—rheumatoid arthritis	4.91e-05	0.000183	CcSEcCtD
Fluoxetine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.9e-05	0.000183	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—rheumatoid arthritis	4.89e-05	0.000182	CcSEcCtD
Fluoxetine—Urticaria—Betamethasone—rheumatoid arthritis	4.86e-05	0.000182	CcSEcCtD
Fluoxetine—Urticaria—Dexamethasone—rheumatoid arthritis	4.86e-05	0.000182	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.86e-05	0.000181	CcSEcCtD
Fluoxetine—Dizziness—Prednisolone—rheumatoid arthritis	4.85e-05	0.000181	CcSEcCtD
Fluoxetine—Asthenia—Triamcinolone—rheumatoid arthritis	4.84e-05	0.000181	CcSEcCtD
Fluoxetine—Body temperature increased—Betamethasone—rheumatoid arthritis	4.84e-05	0.000181	CcSEcCtD
Fluoxetine—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.84e-05	0.000181	CcSEcCtD
Fluoxetine—Abdominal pain—Betamethasone—rheumatoid arthritis	4.84e-05	0.000181	CcSEcCtD
Fluoxetine—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.84e-05	0.000181	CcSEcCtD
Fluoxetine—Asthenia—Methylprednisolone—rheumatoid arthritis	4.83e-05	0.00018	CcSEcCtD
Fluoxetine—Insomnia—Prednisone—rheumatoid arthritis	4.82e-05	0.00018	CcSEcCtD
Fluoxetine—Nausea—Cyclosporine—rheumatoid arthritis	4.79e-05	0.000179	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisone—rheumatoid arthritis	4.79e-05	0.000179	CcSEcCtD
Fluoxetine—Pruritus—Triamcinolone—rheumatoid arthritis	4.77e-05	0.000178	CcSEcCtD
Fluoxetine—Cough—Methotrexate—rheumatoid arthritis	4.76e-05	0.000178	CcSEcCtD
Fluoxetine—Pruritus—Methylprednisolone—rheumatoid arthritis	4.76e-05	0.000178	CcSEcCtD
Fluoxetine—Dizziness—Hydrocortisone—rheumatoid arthritis	4.74e-05	0.000177	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—rheumatoid arthritis	4.73e-05	0.000177	CcSEcCtD
Fluoxetine—Dyspepsia—Prednisone—rheumatoid arthritis	4.69e-05	0.000175	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—rheumatoid arthritis	4.65e-05	0.000174	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—rheumatoid arthritis	4.65e-05	0.000174	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—rheumatoid arthritis	4.65e-05	0.000174	CcSEcCtD
Fluoxetine—Decreased appetite—Prednisone—rheumatoid arthritis	4.64e-05	0.000173	CcSEcCtD
Fluoxetine—Rash—Prednisolone—rheumatoid arthritis	4.63e-05	0.000173	CcSEcCtD
Fluoxetine—Dermatitis—Prednisolone—rheumatoid arthritis	4.62e-05	0.000173	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	4.62e-05	0.000172	CcSEcCtD
Fluoxetine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	4.61e-05	0.000172	CcSEcCtD
Fluoxetine—Fatigue—Prednisone—rheumatoid arthritis	4.6e-05	0.000172	CcSEcCtD
Fluoxetine—Headache—Prednisolone—rheumatoid arthritis	4.6e-05	0.000172	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—rheumatoid arthritis	4.59e-05	0.000171	CcSEcCtD
Fluoxetine—Constipation—Prednisone—rheumatoid arthritis	4.56e-05	0.00017	CcSEcCtD
Fluoxetine—Vomiting—Hydrocortisone—rheumatoid arthritis	4.56e-05	0.00017	CcSEcCtD
Fluoxetine—Rash—Hydrocortisone—rheumatoid arthritis	4.52e-05	0.000169	CcSEcCtD
Fluoxetine—Dermatitis—Hydrocortisone—rheumatoid arthritis	4.51e-05	0.000169	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—rheumatoid arthritis	4.49e-05	0.000168	CcSEcCtD
Fluoxetine—Headache—Hydrocortisone—rheumatoid arthritis	4.49e-05	0.000168	CcSEcCtD
Fluoxetine—Dizziness—Triamcinolone—rheumatoid arthritis	4.46e-05	0.000167	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—rheumatoid arthritis	4.46e-05	0.000166	CcSEcCtD
Fluoxetine—Dizziness—Methylprednisolone—rheumatoid arthritis	4.45e-05	0.000166	CcSEcCtD
Fluoxetine—Infection—Methotrexate—rheumatoid arthritis	4.43e-05	0.000165	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisone—rheumatoid arthritis	4.39e-05	0.000164	CcSEcCtD
Fluoxetine—Asthenia—Dexamethasone—rheumatoid arthritis	4.39e-05	0.000164	CcSEcCtD
Fluoxetine—Asthenia—Betamethasone—rheumatoid arthritis	4.39e-05	0.000164	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—rheumatoid arthritis	4.36e-05	0.000163	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4.36e-05	0.000163	CcSEcCtD
Fluoxetine—Nausea—Prednisolone—rheumatoid arthritis	4.36e-05	0.000163	CcSEcCtD
Fluoxetine—Pruritus—Dexamethasone—rheumatoid arthritis	4.33e-05	0.000162	CcSEcCtD
Fluoxetine—Pruritus—Betamethasone—rheumatoid arthritis	4.33e-05	0.000162	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—rheumatoid arthritis	4.33e-05	0.000162	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	4.31e-05	0.000161	CcSEcCtD
Fluoxetine—Vomiting—Triamcinolone—rheumatoid arthritis	4.29e-05	0.00016	CcSEcCtD
Fluoxetine—Vomiting—Methylprednisolone—rheumatoid arthritis	4.28e-05	0.00016	CcSEcCtD
Fluoxetine—Nausea—Hydrocortisone—rheumatoid arthritis	4.26e-05	0.000159	CcSEcCtD
Fluoxetine—Rash—Triamcinolone—rheumatoid arthritis	4.25e-05	0.000159	CcSEcCtD
Fluoxetine—Dermatitis—Triamcinolone—rheumatoid arthritis	4.25e-05	0.000159	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—rheumatoid arthritis	4.25e-05	0.000159	CcSEcCtD
Fluoxetine—Rash—Methylprednisolone—rheumatoid arthritis	4.25e-05	0.000158	CcSEcCtD
Fluoxetine—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.24e-05	0.000158	CcSEcCtD
Fluoxetine—Urticaria—Prednisone—rheumatoid arthritis	4.24e-05	0.000158	CcSEcCtD
Fluoxetine—Headache—Triamcinolone—rheumatoid arthritis	4.23e-05	0.000158	CcSEcCtD
Fluoxetine—Headache—Methylprednisolone—rheumatoid arthritis	4.22e-05	0.000157	CcSEcCtD
Fluoxetine—Abdominal pain—Prednisone—rheumatoid arthritis	4.22e-05	0.000157	CcSEcCtD
Fluoxetine—Body temperature increased—Prednisone—rheumatoid arthritis	4.22e-05	0.000157	CcSEcCtD
Fluoxetine—Diarrhoea—Dexamethasone—rheumatoid arthritis	4.19e-05	0.000156	CcSEcCtD
Fluoxetine—Diarrhoea—Betamethasone—rheumatoid arthritis	4.19e-05	0.000156	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—rheumatoid arthritis	4.16e-05	0.000155	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	4.06e-05	0.000152	CcSEcCtD
Fluoxetine—Dizziness—Betamethasone—rheumatoid arthritis	4.05e-05	0.000151	CcSEcCtD
Fluoxetine—Dizziness—Dexamethasone—rheumatoid arthritis	4.05e-05	0.000151	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—rheumatoid arthritis	4.03e-05	0.00015	CcSEcCtD
Fluoxetine—Nausea—Triamcinolone—rheumatoid arthritis	4.01e-05	0.00015	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—rheumatoid arthritis	4e-05	0.000149	CcSEcCtD
Fluoxetine—Nausea—Methylprednisolone—rheumatoid arthritis	4e-05	0.000149	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—rheumatoid arthritis	3.97e-05	0.000148	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—rheumatoid arthritis	3.96e-05	0.000148	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisone—rheumatoid arthritis	3.93e-05	0.000147	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—rheumatoid arthritis	3.92e-05	0.000146	CcSEcCtD
Fluoxetine—Vomiting—Betamethasone—rheumatoid arthritis	3.89e-05	0.000145	CcSEcCtD
Fluoxetine—Vomiting—Dexamethasone—rheumatoid arthritis	3.89e-05	0.000145	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—rheumatoid arthritis	3.87e-05	0.000145	CcSEcCtD
Fluoxetine—Rash—Betamethasone—rheumatoid arthritis	3.86e-05	0.000144	CcSEcCtD
Fluoxetine—Rash—Dexamethasone—rheumatoid arthritis	3.86e-05	0.000144	CcSEcCtD
Fluoxetine—Dermatitis—Betamethasone—rheumatoid arthritis	3.86e-05	0.000144	CcSEcCtD
Fluoxetine—Dermatitis—Dexamethasone—rheumatoid arthritis	3.86e-05	0.000144	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.85e-05	0.000144	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—rheumatoid arthritis	3.84e-05	0.000143	CcSEcCtD
Fluoxetine—Headache—Dexamethasone—rheumatoid arthritis	3.84e-05	0.000143	CcSEcCtD
Fluoxetine—Headache—Betamethasone—rheumatoid arthritis	3.84e-05	0.000143	CcSEcCtD
Fluoxetine—Asthenia—Prednisone—rheumatoid arthritis	3.83e-05	0.000143	CcSEcCtD
Fluoxetine—Pain—Methotrexate—rheumatoid arthritis	3.81e-05	0.000142	CcSEcCtD
Fluoxetine—Pruritus—Prednisone—rheumatoid arthritis	3.77e-05	0.000141	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—rheumatoid arthritis	3.67e-05	0.000137	CcSEcCtD
Fluoxetine—Diarrhoea—Prednisone—rheumatoid arthritis	3.65e-05	0.000136	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.64e-05	0.000136	CcSEcCtD
Fluoxetine—Nausea—Dexamethasone—rheumatoid arthritis	3.64e-05	0.000136	CcSEcCtD
Fluoxetine—Nausea—Betamethasone—rheumatoid arthritis	3.64e-05	0.000136	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—rheumatoid arthritis	3.54e-05	0.000132	CcSEcCtD
Fluoxetine—Dizziness—Prednisone—rheumatoid arthritis	3.53e-05	0.000132	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—rheumatoid arthritis	3.52e-05	0.000132	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—rheumatoid arthritis	3.52e-05	0.000132	CcSEcCtD
Fluoxetine—Vomiting—Prednisone—rheumatoid arthritis	3.39e-05	0.000127	CcSEcCtD
Fluoxetine—Rash—Prednisone—rheumatoid arthritis	3.36e-05	0.000126	CcSEcCtD
Fluoxetine—Dermatitis—Prednisone—rheumatoid arthritis	3.36e-05	0.000125	CcSEcCtD
Fluoxetine—Headache—Prednisone—rheumatoid arthritis	3.34e-05	0.000125	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.28e-05	0.000123	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—rheumatoid arthritis	3.2e-05	0.000119	CcSEcCtD
Fluoxetine—Nausea—Prednisone—rheumatoid arthritis	3.17e-05	0.000118	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—rheumatoid arthritis	3.15e-05	0.000118	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—rheumatoid arthritis	3.05e-05	0.000114	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—rheumatoid arthritis	2.95e-05	0.00011	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—rheumatoid arthritis	2.83e-05	0.000106	CcSEcCtD
Fluoxetine—Rash—Methotrexate—rheumatoid arthritis	2.81e-05	0.000105	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—rheumatoid arthritis	2.81e-05	0.000105	CcSEcCtD
Fluoxetine—Headache—Methotrexate—rheumatoid arthritis	2.79e-05	0.000104	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—rheumatoid arthritis	2.65e-05	9.88e-05	CcSEcCtD
Fluoxetine—ALB—Hemostasis—MMP1—rheumatoid arthritis	3.79e-06	0.000405	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—MMP3—rheumatoid arthritis	3.79e-06	0.000405	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	3.79e-06	0.000405	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	3.78e-06	0.000404	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	3.78e-06	0.000404	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL2—rheumatoid arthritis	3.76e-06	0.000402	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL3—rheumatoid arthritis	3.76e-06	0.000402	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFATC1—rheumatoid arthritis	3.74e-06	0.0004	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	3.73e-06	0.000399	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCR5—rheumatoid arthritis	3.71e-06	0.000397	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MED1—rheumatoid arthritis	3.71e-06	0.000397	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SAA1—rheumatoid arthritis	3.68e-06	0.000393	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2RA—rheumatoid arthritis	3.66e-06	0.000391	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GC—rheumatoid arthritis	3.63e-06	0.000388	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	3.63e-06	0.000388	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—C3—rheumatoid arthritis	3.63e-06	0.000388	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NCF1—rheumatoid arthritis	3.6e-06	0.000385	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL5—rheumatoid arthritis	3.58e-06	0.000382	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCR6—rheumatoid arthritis	3.57e-06	0.000382	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCR5—rheumatoid arthritis	3.55e-06	0.000379	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—BGN—rheumatoid arthritis	3.54e-06	0.000379	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	3.53e-06	0.000378	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	3.53e-06	0.000378	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	3.52e-06	0.000377	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CSF2—rheumatoid arthritis	3.52e-06	0.000377	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	3.5e-06	0.000374	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MED1—rheumatoid arthritis	3.5e-06	0.000374	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NCF2—rheumatoid arthritis	3.47e-06	0.000372	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	3.47e-06	0.000371	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—C3—rheumatoid arthritis	3.47e-06	0.000371	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MED1—rheumatoid arthritis	3.47e-06	0.000371	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CD28—rheumatoid arthritis	3.46e-06	0.00037	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—FN1—rheumatoid arthritis	3.46e-06	0.00037	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ACP5—rheumatoid arthritis	3.45e-06	0.000369	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	3.45e-06	0.000369	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS2—rheumatoid arthritis	3.42e-06	0.000365	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SH2B3—rheumatoid arthritis	3.39e-06	0.000362	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TRAF6—rheumatoid arthritis	3.39e-06	0.000362	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	3.38e-06	0.000361	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—GZMB—rheumatoid arthritis	3.36e-06	0.00036	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL2—rheumatoid arthritis	3.27e-06	0.000349	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL3—rheumatoid arthritis	3.27e-06	0.000349	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ALOX5—rheumatoid arthritis	3.26e-06	0.000349	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—UBE2D1—rheumatoid arthritis	3.26e-06	0.000349	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.25e-06	0.000348	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.25e-06	0.000348	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.24e-06	0.000347	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCR5—rheumatoid arthritis	3.22e-06	0.000345	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	3.22e-06	0.000345	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	3.22e-06	0.000345	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—BDKRB2—rheumatoid arthritis	3.2e-06	0.000342	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL12—rheumatoid arthritis	3.2e-06	0.000342	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SAA1—rheumatoid arthritis	3.19e-06	0.000342	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—POMC—rheumatoid arthritis	3.19e-06	0.000342	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—BGN—rheumatoid arthritis	3.18e-06	0.00034	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	3.18e-06	0.00034	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.17e-06	0.000339	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6ST—rheumatoid arthritis	3.17e-06	0.000339	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADRBK1—rheumatoid arthritis	3.16e-06	0.000338	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ENO1—rheumatoid arthritis	3.16e-06	0.000338	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—C3—rheumatoid arthritis	3.15e-06	0.000337	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NCF1—rheumatoid arthritis	3.13e-06	0.000334	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—BGN—rheumatoid arthritis	3.1e-06	0.000332	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	3.09e-06	0.00033	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.07e-06	0.000328	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CD28—rheumatoid arthritis	3.01e-06	0.000322	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.98e-06	0.000319	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SYK—rheumatoid arthritis	2.97e-06	0.000318	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MED1—rheumatoid arthritis	2.96e-06	0.000317	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	2.93e-06	0.000313	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—BGN—rheumatoid arthritis	2.93e-06	0.000313	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.92e-06	0.000312	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—BGN—rheumatoid arthritis	2.9e-06	0.00031	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—POMC—rheumatoid arthritis	2.9e-06	0.00031	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	2.88e-06	0.000308	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.87e-06	0.000307	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—STAT1—rheumatoid arthritis	2.87e-06	0.000307	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	2.86e-06	0.000306	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.86e-06	0.000306	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCL2—rheumatoid arthritis	2.84e-06	0.000303	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.83e-06	0.000303	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6R—rheumatoid arthritis	2.83e-06	0.000303	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL10—rheumatoid arthritis	2.83e-06	0.000302	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.8e-06	0.0003	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.8e-06	0.0003	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL12—rheumatoid arthritis	2.78e-06	0.000297	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.78e-06	0.000297	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—POMC—rheumatoid arthritis	2.77e-06	0.000297	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	2.75e-06	0.000294	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	2.75e-06	0.000294	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	2.75e-06	0.000294	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS3—rheumatoid arthritis	2.75e-06	0.000294	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.75e-06	0.000294	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	2.69e-06	0.000288	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	2.67e-06	0.000285	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ENO1—rheumatoid arthritis	2.66e-06	0.000284	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.61e-06	0.000279	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.59e-06	0.000277	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SYK—rheumatoid arthritis	2.58e-06	0.000276	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP3—rheumatoid arthritis	2.58e-06	0.000276	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—TYK2—rheumatoid arthritis	2.58e-06	0.000276	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.57e-06	0.000275	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.53e-06	0.000271	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—POMC—rheumatoid arthritis	2.52e-06	0.000269	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	2.49e-06	0.000266	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PTK2—rheumatoid arthritis	2.48e-06	0.000265	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—BGN—rheumatoid arthritis	2.48e-06	0.000265	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.47e-06	0.000264	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	2.46e-06	0.000263	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	2.46e-06	0.000263	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	2.45e-06	0.000262	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL5—rheumatoid arthritis	2.43e-06	0.00026	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CSF2—rheumatoid arthritis	2.4e-06	0.000256	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.39e-06	0.000255	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—IL2—rheumatoid arthritis	2.36e-06	0.000252	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.35e-06	0.000251	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.35e-06	0.000251	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ENO1—rheumatoid arthritis	2.33e-06	0.000249	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—IL2—rheumatoid arthritis	2.33e-06	0.000249	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.29e-06	0.000245	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.29e-06	0.000244	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.28e-06	0.000244	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CAT—rheumatoid arthritis	2.27e-06	0.000243	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SPP1—rheumatoid arthritis	2.25e-06	0.000241	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.24e-06	0.00024	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	2.24e-06	0.000239	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	2.24e-06	0.000239	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.22e-06	0.000238	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.2e-06	0.000235	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCR5—rheumatoid arthritis	2.19e-06	0.000234	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.18e-06	0.000233	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.18e-06	0.000233	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2RA—rheumatoid arthritis	2.16e-06	0.000231	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	2.15e-06	0.00023	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	2.15e-06	0.000229	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL2—rheumatoid arthritis	2.14e-06	0.000229	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—C3—rheumatoid arthritis	2.14e-06	0.000229	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.14e-06	0.000229	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.12e-06	0.000227	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.12e-06	0.000227	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	2.11e-06	0.000226	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	2.08e-06	0.000223	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.05e-06	0.00022	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	2.05e-06	0.000219	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.01e-06	0.000215	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	1.99e-06	0.000213	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—VEGFA—rheumatoid arthritis	1.98e-06	0.000212	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.96e-06	0.000209	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.95e-06	0.000208	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CAT—rheumatoid arthritis	1.91e-06	0.000205	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.91e-06	0.000205	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.9e-06	0.000204	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MTHFR—rheumatoid arthritis	1.9e-06	0.000203	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	1.88e-06	0.000201	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.88e-06	0.000201	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.87e-06	0.0002	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.87e-06	0.0002	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.86e-06	0.000199	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	1.86e-06	0.000199	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	1.86e-06	0.000199	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	1.85e-06	0.000198	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.83e-06	0.000196	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TGFB1—rheumatoid arthritis	1.82e-06	0.000194	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	1.8e-06	0.000193	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.76e-06	0.000188	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.73e-06	0.000185	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.72e-06	0.000184	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.71e-06	0.000183	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.68e-06	0.000179	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.68e-06	0.000179	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.67e-06	0.000179	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.63e-06	0.000175	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.63e-06	0.000174	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.6e-06	0.000171	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MTHFR—rheumatoid arthritis	1.6e-06	0.000171	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.58e-06	0.000169	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.57e-06	0.000168	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.57e-06	0.000167	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.52e-06	0.000163	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—POMC—rheumatoid arthritis	1.52e-06	0.000162	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TP53—rheumatoid arthritis	1.5e-06	0.00016	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.49e-06	0.00016	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.49e-06	0.000159	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.48e-06	0.000159	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.46e-06	0.000156	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.45e-06	0.000155	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.44e-06	0.000153	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.43e-06	0.000153	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.4e-06	0.00015	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—rheumatoid arthritis	1.38e-06	0.000148	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.35e-06	0.000145	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.34e-06	0.000143	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.33e-06	0.000142	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	1.32e-06	0.000142	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.32e-06	0.000141	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.32e-06	0.000141	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.31e-06	0.00014	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.3e-06	0.000139	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.29e-06	0.000138	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—POMC—rheumatoid arthritis	1.28e-06	0.000137	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.27e-06	0.000135	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.26e-06	0.000135	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	1.21e-06	0.000129	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.2e-06	0.000128	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.19e-06	0.000127	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.18e-06	0.000127	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.17e-06	0.000125	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.15e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.15e-06	0.000123	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.12e-06	0.00012	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.12e-06	0.000119	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NOS3—rheumatoid arthritis	1.11e-06	0.000119	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.1e-06	0.000118	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.09e-06	0.000117	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	1.08e-06	0.000115	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.05e-06	0.000113	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.05e-06	0.000112	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.05e-06	0.000112	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.04e-06	0.000111	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.03e-06	0.00011	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.03e-06	0.00011	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.02e-06	0.000109	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—rheumatoid arthritis	1.02e-06	0.000109	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.01e-06	0.000108	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1e-06	0.000107	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	9.88e-07	0.000106	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NOS3—rheumatoid arthritis	9.76e-07	0.000104	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	9.62e-07	0.000103	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—rheumatoid arthritis	9.53e-07	0.000102	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	9.35e-07	0.0001	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	9.2e-07	9.84e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	9.15e-07	9.78e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	9.12e-07	9.75e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	8.93e-07	9.56e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	8.93e-07	9.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	8.62e-07	9.22e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.58e-07	9.17e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	8.41e-07	9e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	8.34e-07	8.92e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	8.15e-07	8.71e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	8.13e-07	8.7e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	7.79e-07	8.33e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	7.44e-07	7.96e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	7.13e-07	7.62e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	7.06e-07	7.55e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	6.9e-07	7.37e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	6.46e-07	6.91e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	6.29e-07	6.72e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	6.01e-07	6.43e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	5.5e-07	5.88e-05	CbGpPWpGaD
